Vaccine Cold Chain in a Continental Country Brazil
|
|
- Jack Rich
- 5 years ago
- Views:
Transcription
1 Vaccine Cold Chain in a Continental Country Brazil GISELE MIRANDA 2018 FLY PHARMA US 11 SEP 2018
2 Fiocruz / Bio-Manguinhos Part of the MoH 118 years old Biggest health institution in Brazil Presence in 10 states + one country in Africa Focus in public Health Activities: R,D&I Education Health assistance Production and supply of medicines and vaccines Museum
3 Immunization in Brazil Vaccination against Smallpox since 1804 Mass vaccination against smallpox in Rio de Janeiro in early 1900 Sanitary reform and elimination of cholera, plague, YF and smallpox results: the vaccine uprising
4 National Immunization Program The success of national vaccination campaign against Smallpox and its erradication in 1971 Establishment of the NIP in 1973 to guarantee the continuity, equity and gratuity Centralized planning and guidance, but shared responsibilities with states and districts
5 National Immunization Program s Callendar age BCG Hep B DTP-HB - Hib At birth Single dose Birth dose OPV/ IPV Pneumo Rota Men C YF MMR Varicella Hep A Td HPV dtpa Influenza 2 months 1 st dose 1 st dose 1 st dose 1 st dose 3 months 1 st dose 4 months 2 nd dose 2 nd dose 2 nd dose 2 nd dose 5 months 2 nd dose 6 months 3 rd dose 3 rd dose 1 st dose 9 months Single dose 16 different vacines 20 diseases > 37 doses / person 12 months Booster dose 1 st Booster Single dose Single dose 15 months 1 st Booster (DTP) 1 st Booster (OPV) Single dose Booster every year 4 years 2 nd Booster(DTP) 2 nd Booster (OPV) 9 years 2 doses doses 2 nd Booster Single dose Booster every 10 years years years 3 doses Single dose Booster every 10 years doses Single dose Booster every 10 years Booster every year Pregnant 3 doses 2 doses Single dose
6 Why is it a big challenge?
7 Continental country: km² (US km²) districts 208.7K inhabitants (US 325,7 milhões)
8 Road infrastructure: km roads only 12,3% are paved roads
9 More than immunization facilities
10 Large urban áreas (São Paulo 12.1 million 7th bigger city of the world) X Rural areas (15% in isolated areas)
11 2018 Population pyramid Large population of children under 4Yrs + 14,8K under 4yrs 26,4K over 60 yrs Growing population over 60ysr men women 2010
12
13 A long way to reach one child A journey to an Amazonian village
14 Vaccine Distribution Scheme Decentralized control of the operations and resources (industry, MoH, States, Districts...) NIP is responsible for the guidance and training Shared responsibilities for the information and planning
15 Temperature sensitivity of vaccines
16 Acceptable Acceptable Acceptable WHO recommended vaccine storage temperatures and maximum storage periods National (up to 12 months) Sub-National (up to 6 months) District (up to 3 months) Service (up to 1 months) +8ºC Liquid Lyophil Liquid Lyophil Liquid Lyophil Liquid Lyophil +2ºC All OPV -15ºC All OPV Lyophil All OPV Lyophil All OPV Lyophil -25ºC
17 Bio-Manguinhos (vaccine manufacturer)
18 CENADI (Vaccine s National Storage and Distribution Center)
19 Special cold box design
20
21 Sub-national central stores
22 Going to the last mile
23
24 Support from the Brazilian Army
25
26 Immunization room - routine
27 Outreach immunization National Immunization day
28 Open markets Schools Beaches Parks Churches...
29
30 Never loose the opportunity to vaccinate
31
32 How to ensure the quality of the service? Right product Right quantity Right condition Right place Right time Right cost
33 Cold Chain Guidelines - NIP Guidelines of Good Storage and Distribution Practices revised consistently Types and characteristics of each immunobiological Thermodinamics Maintenance of equipments Quality system Safety guidelines Control and monitoring instruments Supply planning tools New Technologies
34 Preparing the dose Handling the vacines How to administer MDVP Never loose the opportunity to vaccinate
35 Temperature control devices Temperature mesuring devices Wired digital thermometer Cold room Cold box (transport) Cold box (immunization room) Infrared thermometer Datalogger Fridge tag Freeze tag
36 CTC a disruptive aproach
37 Controlled Temperature Chain - CTC An optional method of transporting and storing vaccines in carriers without icepacks up to specific number of days before the vaccines are used Only for campaign or special strategy setting. Support +40 C for a minimum of 3 days and must have: A vaccine vial monitor (VVM) on each vial, and A peak threshold indicator in each vaccine carrier. The vaccine must be licensed for use in a CTC (WHO PQ and NRA)
38 Why is it useful? Fewer resouces Easier outreach Increased coverage
39 CTC Pilots in Africa Priority vaccines to be used in CTC: - Human papillomavirus (HPV); - Oral cholera vaccine (OCV); - Tetanus toxoid vaccine - Hepatitis B vaccine birth dose (HepB-BD). Already in use in estern, central and subsaarian africa
40 New Technologies and approaches Thank you! Gisele Miranda
Role of Partnerships in Developing Innovative Vaccines: Brazil
Role of Partnerships in Developing Innovative Vaccines: Brazil SAGE Meeting, October 2010 Reinaldo Guimarães, M.D, MSc. Secretary of Science, Technology and Strategic Inputs Ministry of Health of Brazil
More informationachievements, challenges and financing
National Immunization Program: achievements, challenges and financing Lais Martins de Aquino National Immunization Program Department of Transmissible Disease Surveillance Health Surveillance Secretariat
More informationLast mile vaccine distribution to rural health centres. Faheem Merchant
Last mile vaccine distribution to rural health centres Faheem Merchant New Global Immunization Goals 2000 - Millennium Development Goal # 4 Reduce under 5 child mortality by 2/3 between 1990 and 2015.
More informationProgramme update. Prequalification of Vaccines
Programme update Prequalification of Vaccines UN Prequalification of Medicines, Diagnostics and Vaccines 6th Consultative Stakeholder Meeting 4 April 2011 David Wood, WHO/IVB/QSS Outline Good news - A
More informationThe Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
More informationHeat and Freeze Sensitivity of Vaccines
Heat and Freeze Sensitivity of Vaccines DCVMN Workshop "Vaccine quality management systems for manufacturing excellence" Michael Rush, MBA Executive Director - Global Health Policy October 24-25, 2013
More informationUNICEF s perspective. WHO Informal Consultation to develop further guidance on vaccines for the UNEP-convened INC4 Geneva, 3-4 April 2012
UNICEF s perspective WHO Informal Consultation to develop further guidance on vaccines for the UNEP-convened INC4 Geneva, 3-4 April 2012 UNICEF procures immunization supplies on behalf of around 100 countries
More informationPreventing Accidental Freezing in the Cold Chain. An introduction to cold chain freezing and some options for reducing it.
Preventing Accidental Freezing in the Cold Chain An introduction to cold chain freezing and some options for reducing it. Program for Appropriate Technology in Health (PATH) 4/2003 Topics Presented Freezing
More informationGlobal update on temperature monitoring
Global update on temperature monitoring Why bother about temperature monitoring Objectives of the immunization supply chain Impacts of temperature excursions If undetected If detected Availability of vaccines
More informationManaging constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,
Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October 5-7 2015 Bangkok, Thailand UNICEF has a key role in vaccine procurement and
More informationCHILD REGISTRATION FORM
CHILD REGISTRATION FORM 030 011 Health facility code 1232-21348 1342-21353 7654-87213 1092-43579 9876-12431 1432-12322 030 011 CHILD REGISTRATION FORM 030 012 2354-46789 6512-23659 3243-54657 4354-65768
More informationUNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013
UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013 Presentation overview Scope of UNICEF procurement Overview of UNICEF procurement Vaccine market updates UNICEF procures
More informationA vaccine s journey: the many steps to saving lives
A vaccine s journey: the many steps to saving lives GW-USAID Mini-University 7 March 2014 Endale Beyene, MA, MPH Rebecca Fields, MPH Angela Shen, ScD, MPH Outline I. What is the problem and where are we
More informationStatus and challenges
National Immunization Program Brazil Status and challenges Carla Magda A. S. Domingues Ministry of Health of Brazil Department of Health Surveillance Department of Communicable Disease Surveillance General
More informationExpanded Programme on Immunization (EPI):
Expanded Programme on Immunization (EPI): Introduction Four to five million annual deaths could be prevented by 2015 through sustained and appropriate immunization efforts, backed by financial support.
More informationAdolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
More informationThailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand
Thailand Expanded Program on Immunization Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand Outline Expanded Program on Immunization Organization Immunization
More informationMichel BAIJOT Vice President, WW Business Development & Strategic Alliances
Technology Transfer and Vaccines: The GSK Experience WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Geneva, November 30th, 2010 Michel BAIJOT Vice President, WW Business
More informationSyrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation
Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation Background Information Immunisation services in Syria Syria had good immunisation services,
More informationCase Study: The Policy for the Introduction of New Vaccines in Brazil
Case Study: The Policy for the Introduction of New Vaccines in Brazil CARLA MAGDA ALLAN SANTOS DOMINGUES, ANTÔNIA MARIA TEIXEIRA, AND SANDRA MARIA DEOTTI CARVALHO 2 Case Study: The Policy for the Introduction
More informationOpportunities and challenges with introduction of newer vaccines: What is needed from the next generation of vaccines
Opportunities and challenges with introduction of newer vaccines: What is needed from the next generation of vaccines Samba O. Sow Julie Milstien CVD- Mali and Baltimore, USA MSF-Oxfam Consultation Geneva,
More informationVaccine Storage in Remote Areas
Vaccine Storage in Remote Areas Lu Aye International Technologies Centre (IDTC) Department of Civil & Environmental Engineering The University of Melbourne lua@unimelb.edu.au The 2 nd Annual Nossal Global
More informationThis document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo
REVISED : OCTOBER 2010 This document was published by: The National Department of Health Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo Copies may be obtained from: The National Department
More informationHow does Gavi make vaccine investment decisions?
How does Gavi make vaccine investment decisions? Judith Kallenberg Global Vaccine and Immunization Research Forum Johannesburg, South-Africa, 16 March 2016 www.gavi.org Vaccine Investment Strategy (VIS)
More informationCurrent National Immunisation Schedule Dr Brenda Corcoran National Immunisation Office.
Current National Immunisation Schedule 2012 Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake rates School
More informationIndicative operational, financial and environmental impact of Thiomersal-free vaccines
Indicative operational, financial and environmental impact of Thiomersal-free vaccines Anthony Battersby & Andrew Garnett FBA Health Systems Analysts 18 th April 2012 1 Methodology Questionnaire sent to
More informationCOMBINATION VACCINES: HOW AND WHY? LESSONS LEARNED.
COMBINATION VACCINES: HOW AND WHY? LESSONS LEARNED. Global Vaccine and Immunization Research Forum Johannesburg, March 16, 2016 Michel De Wilde, MDWConsultant, LLC STRONG RATIONALE EXISTS FOR COMBINATION
More informationHepatitis B vaccination of newborns in rural China: evaluation of an out-of-coldchain delivery strategy. Istanbul, Turkey March 15-17, 2006
Hepatitis B vaccination of newborns in rural China: evaluation of an out-of-coldchain delivery strategy Istanbul, Turkey March 15-17, 2006 Contents Introduction Objective Methods and Implementation Results
More informationQuality assurance for essential medicines and health products: moving towards an harmonized approach
Quality assurance for essential medicines and health products: moving towards an harmonized approach Prequalification of vaccines David Wood QSS/EMP/WHO 12 December 2012 A growing portion of vaccines procured
More informationGAVI S VACCINE INVESTMENT STRATEGY
GAVI S VACCINE INVESTMENT STRATEGY Judith Kallenberg, Head of Policy PDVAC 22 June 2017, Geneva Reach every child www.gavi.org Gavi finances vaccines and immunisation through three routes ($9 Billion in
More informationDCVMN VVM Overview Webinar
DCVMN VVM Overview Webinar July 2018 Temptime Vision and Mission Vision: Temptime elevates the quality of global health Mission: We innovate cost-effective monitoring solutions for environmentally sensitive
More informationCase Studies on Monitoring the Heat and Freeze Sensitive of Vaccines
Case Studies on Monitoring the Heat and Freeze Sensitive of Vaccines DCVMN Workshop "Vaccine quality management systems for manufacturing excellence" Michael Rush, MBA Executive Director - Global Health
More informationCOMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP
34 Buletin Kesihatan Masyarakat Isu Khas 2000 COMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP Rahman. I.* ABSTRACT Infectious diseases are the world's leading cause of death. Vaccines
More informationGAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013
GAVI Alliance Aurelia Nguyen, Director Policy & Market Shaping IPC Meeting 30 May 2013 GAVI Update GAVI Alliance Overview 4 Strategic Goals 3 Market Shaping Objectives GAVI Supported Vaccines Critical
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationRequirements for new trials to examine offtarget. vaccination. Workshop on: Off-target (heterologous/non-specific) effects of vaccination.
Requirements for new trials to examine offtarget effects of vaccination Workshop on: Off-target (heterologous/non-specific) effects of vaccination Les Pensieres Jun 8-10, 2015 PEM Fine London School of
More informationStainless-steel vs Single-use: The Vaccines Perspective
Stainless-steel vs Single-use: The Vaccines Perspective CMO-Biomanufacturer Panel Tue 21 April, Noon-1:30pm, Exhibit Hall Daniel C.Vellom, PhD Sr. Director Global Technology Innovation 2015 INTERPHEX 1
More informationHistory and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8
History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop
More informationExpanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationWHO Recommendations and Guidelines for the Prevention of Perinatal Hepatitis B and Use of Hepatitis B Vaccines
WHO Recommendations and Guidelines for the Prevention of Perinatal Hepatitis B and Use of Hepatitis B Vaccines Steven Wiersma,, Medical Officer WHO/EPI EPI,, Geneva March, 2006 Epidemiology Strategy WHO
More informationFrequently asked questions (FAQs) on MR vaccination campaign. Training Workshop for Measles-Rubella Vaccination Campaigns
Frequently asked questions (FAQs) on MR vaccination campaign Training Workshop for Measles-Rubella Vaccination Campaigns What are measles/rubella diseases? Measles is a highly infectious disease causing
More informationCopyright regulations Warning
COMMONWEALTH OF AUSTRALIA Copyright regulations 1969 Warning This material has been reproduced and communicated to you by or on behalf of the University of Melbourne pursuant to part VB of the Copyright
More informationCyprus Experience. Dr. Elena Papamichael Ministry of Health
Cyprus Experience Dr. Elena Papamichael Ministry of Health Cyprus became independent on1960. On 1974, Turkish troops invaded in the island disturbing the willing for peaceful living. Since then, Turkey
More informationTHIS FORM IS FOR MEDICAL STUDENTS ONLY IMMUNIZATION RECORD
Student Health Requirements Student health forms (physical exam and immunization records) are due in the Office of Clinical Education by March 1st for those students admitted on or before December 31st,
More informationHealthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
More informationDeployment of Combination Vaccines and STI vaccines
Deployment of Combination Vaccines and STI vaccines Advancing Prevention Technologies for Sexual and Reproductive Health Symposium Berkeley, Ca March 24, 2009 Eileen Yamada, MD, MPH California Department
More informationEXPANDED PROGRAM OF IMMUNIZATION (EPI) Definition Program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women.
EXPANDED PROGRAM OF IMMUNIZATION (EPI) Definition Program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women. Strategy A. Child immunization Egyptian immunization
More informationEstablishing a cholera stockpile: What do we need? Alejandro Costa Epidemic Readiness and Intervention
Establishing a cholera stockpile: What do we need? Alejandro Costa Epidemic Readiness and Intervention Outline 1. Experience Meningococcal vaccine stockpile Yellow Fever vaccine stockpile 2. Criteria for
More informationExpanded Programme on Immunization (EPI)
Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationImmunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
More informationFrequently asked questions (FAQs) on MR vaccination campaign
Frequently asked questions (FAQs) on MR vaccination campaign What are measles/rubella diseases? Measles is a highly infectious disease causing illness and death due to complications in the form of diarrhea,
More informationCONTROLLED TEMPERATURE CHAIN:
Photo: WHO/WPRO CONTROLLED TEMPERATURE CHAIN: Myths & Truths Innovative Solutions & Approaches TechNet 2017 Wednesday, 18 October 2017 Anna-Lea Kahn WHO/IVB, Switzerland Joe Woodring WHO/WPRO, Philippines
More informationThe Financial Sustainability of New Vaccine Introduction in the Poorest Countries :
The Financial Sustainability of New Vaccine Introduction in the Poorest Countries : Evidence from the First Phase of GAVI (Global Alliance for Vaccines and Immunization) Patrick Lydon lydonp@who.int Session:
More informationVACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine
VACCINES TRIUMPHS AND TRIBULATIONS William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine Never in the history of human progress has a better and cheaper
More informationVaccines Prevent Illness
Vaccines Prevent Illness Vaccinations, also called immunizations, can prevent many illnesses that might otherwise make people sick or even cause death. Vaccines work by strengthening the body s immune
More informationExercise: Estimating immunization program costs (~60 minutes)
Exercise: Estimating immunization program costs (~60 minutes) Overview Information on the cost of procuring vaccines and of running national immunization program is a key factor in planning and managing
More informationWalter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center
Could Vaccines be a Possible Model For Pediatric Drug Development? June 13, 2006 Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate
More informationGAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing
More informationUNICEF Safe Injection Equipment Key highlights
Safe Injection Equipment VPPEF 03 October 2017 UNICEF Safe Injection Equipment Key highlights Nagwa Hasanin, HTC Vaccine Pharmaceutical form Route of administration Liquid Freeze- dried oral Inject Site
More informationImproving the vaccine supply chain in developing countries via increasing freeze protected cold chain equipment. October, 2014
Improving the vaccine supply chain in developing countries via increasing freeze protected cold chain equipment October, 2014 CHAI s mission is to save lives by increasing access to health commodities
More informationWHO Guidance Note: Vaccine Diluents
WHO Guidance Note: Vaccine Diluents Revision 2015 THE PROPER HANDLING AND USE OF VACCINE DILUENTS This document was published by the Expanded Programme on Immunization of the Department of Immunization,
More informationOVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9
More informationTable Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines
Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND
More informationPrimary Vaccine Container Roundtable: Modeling
Primary Vaccine Container Roundtable: Modeling Bruce Y. Lee, MD, MBA Associate Professor of Medicine, Epidemiology, and Biomedical Informatics University of Pittsburgh HERMES Vision Data on Supply Chain
More informationBCG. Program Management. Vaccine Quality
Program Management 50_16 To change from general to selective BCG vaccination, an efficient notification system must be in place in addition to the following criteria: an average annual notification rate
More informationGavi s Vaccine Investment Strategy
Gavi s Vaccine Investment Strategy Judith Kallenberg, Head of Policy WHO Product Development for Vaccines Advisory Committee Meeting Geneva, Switzerland, 7-9 September 2015 www.gavi.org Vaccine Investment
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationExpanded Programme on Immunization (EPI)
Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationDr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya
Dr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya Presentation Outline Background Immunization Performance review Available Opportunities for engagement Planned and ongoing strategies- New
More informationTotal population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
More informationExpanded Programme on Immunization (EPI)
Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing
More informationNew Vaccines in SA. Regulatory Perspectives James Southern 2015
New Vaccines in SA Regulatory Perspectives James Southern 2015 Outline Regulatory Environment of new vaccines Clinical Trials Application procedures HIV Vaccines Other new vaccines in development Ongoing
More informationCHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES
CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o
More informationNHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11
NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11 NHS GRAMPIAN IMMUNISATION STEERING GROUP March 2012 1 Table of Content 1. Purpose of this report.3 2. Uptake of immunisation: key points during
More informationTowards the Achievement of GHSA 2024 s Overarching Targets
정보화파트업무계획 [GHSA] Immunization Towards the Achievement of GHSA 2024 s Overarching Targets 2016년추진업무및 2017년업무계획 ( 사업관리 ) 7 th November 2018 Korea Centers for Disease Control and Prevention I. Overview Contents
More informationHepatitis B prevention in Malaysia
Hepatitis B prevention in Malaysia Presented by Dr A aisah binti Senin Head of Vaccine Preventable Diseases & Food and Water Bourne Diseases Disease Control Division, Ministry of Health Malaysia 1990 1991
More information7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids Contents Introduction Nunavut Recommended Childhood Immunization Schedule Nunavut Routine Adult Immunization Schedule Nunavut Immunization
More informationECONOMICS OF THE VACCINE MARKET: SIZE, GROWTH AND REVENUES
ECONOMICS OF THE VACCINE MARKET: SIZE, GROWTH AND REVENUES 1 Relationship between research funding and burden of disease Source: Global Forum for Health Research Monitoring Financial Flows for Health Research
More informationNational Immunization Program: Historical and Contemporary Perspectives
National Immunization Program: Historical and Contemporary Perspectives Manish Chaturvedi, R. Roy and S. Mukherjee Department of Community Medicine, School of Medical Sciences & Research, Sharda University,
More informationWHO Update Tania Cernuschi & Patrick Lydon
IVB/EPI/STF WHO Update Tania Cernuschi & Patrick Lydon Session 2 UNICEF Vaccine Industry Consultation 5-6 October 2017 IVB/EPI/STF 1 The Big Picture WHO s Immunization Department Supply, Technologies and
More informationMenA vaccine Introduction Country Experience, Ethiopia
MenA vaccine Introduction Country Experience, Ethiopia Meningitis Vaccine Project, Closure Conference February 22, 2016 Addis Ababa, Sheraton Hotel Background ü Country background ü EPI Background Meningococcal
More informationVaccine Storage and Cold Chain
REVIEW ARTICLE April 2014 / Vol. 4 / Issue 2 Vaccine Storage and Cold Chain Amol R Dongre Professor of Community Medicine, Sri Mankula Vinayagar Medical College, Puducherry Objectives: Describe the importance
More informationimmunisation in New Zealand
This appendix details the history of. Section A1.1 is a brief summary of when each vaccine was introduced to the National Immunisation Schedule (the Schedule). This summary includes vaccines which were
More informationNational Vaccine Plan: From Strategy to Implementation
National Vaccine Plan: From Strategy to Implementation July 26, 2011 Sarah Landry Senior Advisor, National Vaccine Program Office Office of the Assistant Secretary for Health Department of Health and Human
More informationImmunization Update Texas Immunization Conference
Immunization Update 2017 Texas Immunization Conference Agenda NIS Child and Teen Coverage Levels Adult Program Updates TVFC Influenza Updates TVFC Program Updates 2 1 CDC National Immunization Survey Childhood
More informationACIP Meeting Update, New Recommendations and Pending Influenza Season
ACIP Meeting Update, New Recommendations and Pending Influenza Season February 17 th 2011 www.immunizetexas.com ACIP Upcoming Agenda and New Recommendations ACIP (February 23-24 th 2011) Topics for meeting
More informationChapter 23.4 Vaccine Storage and Cold Chain Karan Singh Sagar, Manish Jain. The Childhood Years PART V MORE ON THIS TOPIC
906 IN A NUTSHELL The Childhood Years PART V 1. Proper scheduling of available vaccine is the key to proper utilization of available vaccines and achieving good protection against prevailing VPDs. 2. The
More informationThe Cold Chain and Vaccine storage
The Cold Chain and Vaccine storage Cliona Kiersey Chief Pharmacist National Immunisation Office Objectives To explain the cold chain and vaccine delivery service including use of vaccine returns service
More informationVACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
More informationPentabio Vaccine (DTP-HB-Hib)
SUMMARY OF PRODUCT CHARACTERISTICS Product Name Pharmaceutical Form Strength Presentation : Pentabio : Suspension for injection : 1, 5 and 10 doses : Box of 10 vials @ 0.5 ml Box of 10 vials @ 2.5 ml Box
More informationAppendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
More informationPentavalent Market. UNICEF/UN074464/Lister. UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation
Pentavalent Market UNICEF/UN074464/Lister UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation UNICEF/UN074371/Dragaj OUTLINE Historical demand and market overview Healthy Market Current Tender 2017-2019
More information7Monitoring and using your data
7Monitoring and using your data 7: Monitoring and using your data About this module This module discusses how to collect and report data, and how to monitor your performance using your own data. It also
More informationImmunization Guidelines for the Use of State Supplied Vaccine April 18, 2013
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationVaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines
Vaccine Innovation: Challenges and Opportunities to Protect Health Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines Protecting Health with Vaccines HEALTH IMPROVEMENT Population Impact Guidelines
More information1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector
1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share
More informationImmunization. Historical point
Immunization Historical point In 1796 Edward Jenner s use of material from cowpox pustules to provide protection against smallpox. Louis Pasteur s 1885 rabies was the next to make an impact on human disease
More informationImmunization Guidelines For the Use of State Supplied Vaccine July 1, 2011
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationRECOMMENDED IMMUNIZATIONS
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States 2010 1 2 4 6 12 15 18 19 23 2 3 4 6 Vaccine Age Birth month months months months months months months months years years
More information